Sutton Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-14
| Closed | -$1.67K | – | 1285 |
|
|
2022
Q4 | $1.67K | Hold |
14
| – | – | ﹤0.01% | 1231 |
|
|
2022
Q3 | $1.49K | Hold |
14
| – | – | ﹤0.01% | 1222 |
|
|
2022
Q2 | $1.37K | Sell |
14
-149
| -91% | -$14.5K | ﹤0.01% | 1227 |
|
|
2022
Q1 | $15.3K | Buy |
163
+3
| +2% | +$281 | 0.01% | 807 |
|
|
2021
Q4 | $13.6K | Buy |
160
+11
| +7% | +$937 | ﹤0.01% | 829 |
|
|
2021
Q3 | $14.3K | Hold |
149
| – | – | 0.01% | 799 |
|
|
2021
Q2 | $14.5K | Hold |
149
| – | – | 0.01% | 795 |
|
|
2021
Q1 | $14.5K | Hold |
149
| – | – | 0.01% | 767 |
|
|
2020
Q4 | $14.3K | Hold |
149
| – | – | 0.01% | 706 |
|
|
2020
Q3 | $14.3K | Hold |
149
| – | – | 0.01% | 642 |
|
|
2020
Q2 | $18.2K | Hold |
149
| – | – | 0.01% | 563 |
|
|
2020
Q1 | $12.9K | Hold |
149
| – | – | 0.01% | 585 |
|
|
2019
Q4 | $16K | Hold |
149
| – | – | 0.01% | 684 |
|
|
2019
Q3 | $13.4K | Hold |
149
| – | – | 0.01% | 708 |
|
|
2019
Q2 | $12.6K | Hold |
149
| – | – | 0.01% | 723 |
|
|
2019
Q1 | $13.1K | Hold |
149
| – | – | 0.01% | 713 |
|
|
2018
Q4 | $10.6K | Hold |
149
| – | – | 0.01% | 729 |
|
|
2018
Q3 | $18.3K | Hold |
149
| – | – | 0.01% | 621 |
|
|
2018
Q2 | $14.6K | Hold |
149
| – | – | 0.01% | 719 |
|
|
2018
Q1 | $12.4K | Hold |
149
| – | – | 0.01% | 751 |
|
|
2017
Q4 | $11.6K | Buy |
+149
| New | +$11.6K | 0.01% | 735 |
|